Reuters CureVac, a German-based biotechnology company, jumped $ 213.3 million and more than a third of its IPO price in its initial public offering on Friday. Shares of the company have continued to grow since its Friday IPO, gaining as much as 52% to $ 85 per share on Monday …
Read More »This Bill Gates-backed coronavirus vaccine developer has skyrocketed 431% in just 2 days after going public (CVAC)
